CMSC Thursday, July 24 2008
CMSC Online



 
Home arrow CMSC Online arrow For CMSC Members arrow Annual Meetings
CMSC 2004 Annual Meeting Presentations Print E-mail
2004 CMSC Annual Meeting Presentations

Friday, June 4
SYMPOSIA
1 PEDIATRIC MULTIPLE SCLEROSIS Brenda Banwell, MD, Chair
  • Immunology of MS:Studies in the Immature Immune System
Amit-Bar-Or, MD, FRCPC
  • Genetics of MS: Implications in Pediatric MS
Dessa Sadovnick, PhD
  • Cognitive Impact of MS Onset in Childhood
William MacAllister, PhD
Jon Temme, MA
Brenda Banwell, MD
Jennifer Boyd, RN, MHSc, MSCN

Lynn Macmillan, RN, CNN(C), MSCN
2 CONTROVERSIES IN BRAIN ATROPHY
WHAT AND WHY
Jack Simon, MD, PhD, Chair
  • Natural History of CNS Atrophy in MS
Nancy Richert, MD, PhD
Rohit Bakshi, MD
  • Atrophy as a Treatment Trial Metric
Jack Simon, MD, PhD
  • Clinical Significance of Brain Atrophy in MS
Richard Rudick, MD
3 DEFINING SUBOPTIMAL RESPONSE TO MS TREATMENT Mark Freedman, BSC, MSC, MD, CSPQ, FAAN, FRCPC, CoChair

David Patry, MD, FRCPC, Co-Chair
Daniel Selchen, MD, FRCPC
  • Disease Progression
Mary Lou Myles, MD
Tony Traboulsee, MD
  • Other Markers
Francois Grand"Maison, MD
4 COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM) AND MS Allen Bowling, MD, PhD, Chair
  • Introduction to Complementary and Alternative Medicine (CAM)
Thomas Stewart, PA-C, MS, JD
  • Diet and Omega-3 Fatty Acids Supplementation in MS
Bianca Weinstock-Guttman, MD
Allen Bowling, MD, PhD
  • The Use of Cannabinoids in MS
John Zajicek, MD
PRINCIPLES AND PRACTICE OF MANAGING MS: AN INTRODUCTION (PART I AND II)

This symposium will prepare candidates for the Multiple Sclerosis Certified Specialist (MSCS) Exam
Carol Saunders, RN, BSN, MSCN, Chair
Kathleen Costello, RN, MS, CRNP, MSCN
Colleen Harris, RN, MN, MSCN
Jan Shilling, BSN, RN, CRRN, MSCN
  • Managing Bowel and Bladder Problems in MS
Tracy Walker, RN, CWOCN, FNPC
  • Social Work and Advocacy - A Court Case Presentation
Theresa Jiwa, RN, MSW
  • Care Partner Stress and MS
Mary Elizabeth Quig, PhD
Linda Morgante, RN, MSN, MSCN, CRRN
Nancy Eckert, RN, CSG
  • Caring for Self
Susan Serpico, RN, BS, MSCN
ICODIMS-EVOLVING TREATMENT PATTERNS IN MS: INSIGHTS FROM THE NARCOMS PATIENT REGISTRY Timothy Vollmer, MD, Chair
WORKSHOPS
1 FATIGUE UPDATE
EVALUATION AND MANAGEMENT OF FATIGUE IN MS


(handouts 1 and 2)
R. Philip Kinkel, MD, Co-Chair

Susan Forwell, PhD(cand), MA(OT)C, Co-Chair
2 MANAGING DIFFICULT SYMPTOMS Randall Schapiro, MD
3 BASIC POWERPOINT Ric Goldenberg
4 THE MALE EXPERIENCES IN MS Jodie Haselkorn, MD, MPH, Chair
  • Men with Multiple Sclerosis: Beginning the Discussion
Jodie Haselkorn, MD, MPH
  • Epidemiology
Mitchell T. Wallin, MD, MPH
  • The NARCOMS Registry Data
Olympia Hadjimichael, MPH
  • Disease Mechanisms in Men with MS
James D. Bowen, MD
  • Finances and Work Issues for Men
Robert T. Fraser, PhD, CRC
  • Social Support and MS
Aaron P. Turner, PhD
5 REHABILITATION ASSESSMENTS AND CLINICAL REASONING Brian Hutchinson, MS, PT, ATC, Chair
  • Physical Therapy
Brian Hutchinson, MS, PT, ATC
Pamela Miller Sorensen,MA, CCC-SLP
Jutta Hinrichs, BSc, OT
Judy Soderberg, MSW, LSW
6 "DEDIAGNOSING" MULTIPLE SCLEROSIS Mark Freedman, BSC, MSC, MD, CSPQ, FAAN, FRCPC, Chair
Harold Mersky, DMFRCP, FRCPsyc, FRCPC
  • Moving Beyond an Incorrect Diagnosis
Colleen Harris, RN, MN, MSCN
  • Multiple Sclerosis Mimics
Robert Herndon, MD
  • The Psycho-social Aspects of De-labeling Someone with MS
Deborah Miller, PhD, LISW
7 WHAT SHOULD I KNOW ABOUT THE ROLE OF NEUTRALIZING ANTIBODIES TO A, B, C AND R IN THE TREATMENT OF MS? Joel Oger, MD, FRCPC, Chair
  • The Binding Antibody
Joel Oger, MD, FRCPC
Florian Deisenhammer, MD
  • The Bioavailability
Andrew Pachner, MD
  • How to Evaluate the Effect if NABs on Clinical / MRI Effects of DMDs
Anthony Reder, MD
Saturday, June 5
RESEARCH LECTURE
ANTIMYELIN ANTIBODIES:
PROGNOSTIC VALUE AND CLINICAL IMPLICATIONS
Thomas Berger, MD
LACTRIMS LECTURE
SIGNIFICANCE OF MS RESEARCH IN LATIN AMERICA
Victor Rivera, MD
SYMPOSIA
5 FACING THE CHALLENGES OF SPASTICITY MANAGEMENT IN MS

Francois Bethoux, MD, Chair

Danuta Gogol, RN, CNS/NP, LPC, CLNC

6 COGNITION AND AFFECTIVE DISORDERS IN MS Anthony Feinstein, MD, Chair
Scott Patten, MD, PhD
Peter Arnett, PhD
  • Treatment of Affective Disorders in MS
Sarah Minden, MD
Ralph Benedict, PhD
7 THE HISTORICAL EVOLUTION OF MS TJ Murray, MD, Chair

George Ebers, MD
VA CENTERS OF EXCELLENCE
SECONDARY PROGRESSIVE MS: THERAPEUTIC CHALLENGES
  • Secondary Progressive MS: Clinical Characteristics
Mitchell T. Wallin, MD, MPH
  • Epidemiology of Secondary Progressive MS
Jodie Haselkorn, MD, MPH
  • Symptomatic Treatment
Christopher Bever, Jr., MD
  • Treatment of Secondary Progressive MS
Michael Hatzakis, Jr., MD
  • Neuroplasticity and Rehabilitation Strategies
Robert Shin, MD
  • Cognitive Dysfunction: Therapeutic Challenge
Robert Kane, PhD
  • Inflammation and Secondary Progressive MS: Trials of Immunosupression and Immunomodulators
James Bowen, MD

Ruth Whitnam, MD
  • Neurodegeneration and Secondary Progressive MS: Neuroprotection
Dennis Bourdette, MD
  • Healthcare Use and Expenditures for National Cohort Veterans with MS from 1999 to 2002
Douglas Bradham, DrPH
  • Economic Considerations in Living with MS
Thomas Stripling
WORKSHOPS
8/15 INTERMEDIATE POWERPOINT Ric Goldenberg
9/16 MANAGING SEXUAL DYSFUNCTION IN MULTIPLE SCLEROSIS Patricia Kennedy, RN, CNP
10/17 DIAGNOSTIC DILEMMAS IN MS Patricia Coyle, MD
11/18 ADVANCED PRACTICE NURSING IN MS Kathleen Costello, RN, MS, CRNP, MSCN
12 ETHNOCULTURAL CONSIDERATIONS IN MS

Manuel dela Maza, MD, CHair

Wini Breitbach, RN, MSCN

Victor Rivera, MD

Elida Greinel, RN, BSN, MSCN
Mary Hughes, MD
13/19 SCREENING FOR COGNITIVE IMPAIRMENT IN THE NEUROLOGIST'S OFFICE: COMPUTERIZED NEUROPSYCHOLOGICAL ASSESSMENT AND OTHER QUICK SCREENING TOOLS Jeff Wilken, PhD

Cynthia Sullivan, PhD

Robert Kane, PhD
14/21 REHABILITATION OUTCOMES FOR CLINICAL PRACTICE AND RESEARCH Sandra Brunham, MSc(PT), Chair

Susan Forwell, MA, (OT)C, PhD(cand)

Debrah Miller, PhD, LISW
20 DEVELOPING AN MS SCHOOL Alexander Rae Grant, MD
22 REPRODUCTIVE COUNSELING IN MS Dessa Sadovnick, PhD
Sunday, June 6
COOPERATIVE STUDIES IN MS
CLINICAL TRIAL MANAGEMENT IN MULTIPLE SCLEROSIS
Gary Cutter, PhD, Chair
 
  • Planning a Trial and the Team to Accomplish It
Steven Schwid, MD
  • Study Initiation
Jana Preiningerova, MD
  • Data Collection in Clinical Trials
Michelle Weber, MS, CCRC
  • Why Do Quality Control in Clinical Trials
Monika Baier, PhD